Introduction
In-office needle arthroscopy (IONA) is an emerging minimally invasive technique that enables direct visualization and, in select cases, treatment of intra-articular pathology under local anesthesia in a clinic-based setting. Advances in optics, camera systems, and portal instrumentation have expanded the feasibility of performing diagnostic and therapeutic arthroscopy outside the operating room, thereby reducing reliance on advanced imaging modalities and, in some cases, general anesthesia.
IONA provides several potential advantages over traditional care models. Patients can receive immediate visualization of pathology and, in select cases, undergo definitive treatment in a single encounter. This streamlined care pathway minimizes delays associated with magnetic resonance imaging (MRI), preoperative evaluations, and operating room scheduling. Early studies suggest that IONA can reduce patient burden and resource utilization by accelerating diagnosis and eliminating the need for multiple visits (Voigt et al. 2014). Prior systematic reviews have reported superior diagnostic accuracy in the evaluation of certain knee pathologies, however the procedures included in these analyses were performed in the operating room rather than the office setting (Zhang et al. 2019). Additional studies have reported potential reductions in healthcare costs, increased patient satisfaction, and shorter recovery periods in select populations (Voigt et al. 2014; Gianakos and Kennedy 2024; McMillan, Schwartz, et al. 2017; Mercer, Samsonov, et al. 2022; Munn et al. 2023; Shah et al., n.d.).
Existing systematic reviews have also demonstrated the technical feasibility of needle arthroscopy across multiple joints, including the shoulder, knee, and ankle, with early reports describing its use in conditions such as long head of the biceps tendinopathy, meniscal pathology, and ankle impingement syndromes (Burt et al. 2023). Despite growing clinical interest, however, the available literature remains largely composed of technical reports and small case series, with limited high-quality evidence directly comparing in-office needle arthroscopy to conventional arthroscopy or advanced imaging modalities.
Importantly, prior reviews have focused primarily on diagnostic needle arthroscopy performed in operative settings and have emphasized cost-effectiveness or diagnostic accuracy relative to MRI (Amin et al. 2019; Gill et al. 2018; Wagner et al. 2021). These analyses have not specifically examined procedures performed in the office setting under local anesthesia, nor have they synthesized technical considerations and clinical outcomes across multiple joints. Accordingly, the present study aims to map the existing literature on in-office needle arthroscopy, including diagnostic indications, therapeutic applications, clinical outcomes, complications, and procedural techniques. This scoping review is intended to characterize current clinical experience and identify gaps in the evidence rather than to determine comparative effectiveness. To our knowledge, this study represents the first scoping review synthesizing technical reports and available clinical outcomes literature on the diagnostic and therapeutic indications, outcomes, and complications of IONA.
Methods
Study Eligibility
Articles written in English, published from June 2013 to October 2024, and which analyzed IONA were eligible for inclusion. June 2013 approximates the commercial introduction of small-bore needle arthroscopy systems and 10 years prior to the inception of the current study. These articles were primary literature that assessed diagnostic capability, functional, or patient outcomes or technical reports providing pearls, pitfalls and step-by-step guides to performing IONA. The exclusion criteria included any cadaver studies, animal studies, case reports, reviews, infographics, studies analyzing cost-effectiveness, and studies utilizing needle arthroscopy in the operating room.
Literature Search
A scoping review of PubMed, EMBASE, and Cochrane databases was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analysis for Scoping Review (PRISMA-ScR) guidelines for articles published between June 2013 and October 2024. The following search term was used: (“needle arthroscopy” OR “arthroscopy”) AND (“in-office” or “in office”). Consistent with PRISMA-ScR methodology, this review was designed to map the breadth of available literature rather than perform quantitative synthesis or pooled outcome analysis. Given the heterogeneity of study designs, joints evaluated, procedural indications, and outcome measures, meta-analysis was not feasible and was not attempted. Search strings for each database are listed in Table 1. The search was intentionally broad to capture variations in terminology and indexing related to in-office needle arthroscopy. To mitigate the risk of missing relevant studies, reference lists of all included articles were independently reviewed after full-text screening.
Study Selection and Data Abstraction
Two independent reviewers independently screened all titles, abstracts, full texts, and reference lists. Data extraction was also performed independently in duplicate using a predefined standardized template (Table 2), with disagreements resolved by a senior author. Formal inter-rater agreement statistics (e.g., kappa coefficients) were not calculated for title/abstract or full-text screening stages; this represents a methodological limitation of the present review. Consistent with PRISMA-ScR guidance, inter-rater reliability metrics are not mandated for scoping reviews; however, future scoping reviews in this area should incorporate these statistics to strengthen methodological transparency.
Results
The initial search yielded 57 PubMed, 3 Cochrane, and 83 EMBASE articles. Further sample derivation is listed in Figure 1. Thirty-nine articles were included for full-text review, of which 10 were subsequently excluded. An additional 5 technical reports identified through reference list review were incorporated, yielding a final included sample of 29 studies: 21 technical reports and 8 outcome studies, all with level IV or V evidence categorization.
Study Characteristics
A total of 29 studies (8 outcome, 21 technical reports) were included in this scoping review. Six studies evaluated IONA in the glenohumeral joint (Colasanti et al. 2023; Daggett et al. 2020; Fariyike et al. 2024; Gauci et al. 2021; 2023; Owusu-Sarpong et al. 2023). Ten studies evaluated IONA in the knee (Andreozzi et al. 2022; Annibaldi et al. 2022; Bi et al. 2023; Bradsell et al. 2022; DiBartola et al. 2021; Kirschner et al. 2023; McMillan, Saini, et al. 2017; Neal et al. 2023; Patel et al. 2018; Trang et al. 2022). Twelve studies evaluated IONA in the foot and/or ankle (Butler et al. 2024; 2023; Chen et al. 2022; Colasanti, Kaplan, et al. 2022; Colasanti, Mercer, et al. 2022; Kanakamedala et al. 2022; Dankert et al. 2022; Kaplan et al. 2022; Labib and Slone 2015; Mercer, Gianakos, et al. 2022; Mercer, Azam, et al. 2022). One study evaluated multiple joints (McMillan et al. 2019).
Indications - Diagnosis
Twenty-two studies reported on the diagnostic indications of IONA. For the shoulder, IONA was used to diagnose subacromial impingement, superior labrum anterior to posterior (SLAP) lesions, and LHB tendinopathy (Colasanti et al. 2023; Daggett et al. 2020; Gauci et al. 2021; 2023; Owusu-Sarpong et al. 2023). Intra-articular knee pathology including lesions of the anterior cruciate ligament (ACL), medial and lateral meniscus were commonly diagnosed using IONA (Bradsell et al. 2022; DiBartola et al. 2021; Kirschner et al. 2023; McMillan, Saini, et al. 2017; Patel et al. 2018; McMillan et al. 2019). Additionally IONA in the knee was also used to assess healing of osteochondral allograft implants and ligamentous repair up to 12-24 months after surgery (Annibaldi et al. 2022; Trang et al. 2022). In the foot and ankle, IONA was used to diagnose impingement of the anterior and posterior ankle, and tendinopathy of the flexor hallucis longus (FHL), tibialis posterior, common peroneal muscles and Achilles, anterior talofibular ligament (ATFL) pathology, and hallux rigidus (Mercer, Samsonov, et al. 2022; Butler et al. 2024; 2023; Chen et al. 2022; Colasanti, Kaplan, et al. 2022; Kanakamedala et al. 2022; Dankert et al. 2022; Mercer, Gianakos, et al. 2022). Labib et al. reported IONA for diagnosis of a variety of intra articular foot and ankle pathologies such as osteochondral defects, instability, sinus (Kaplan et al. 2022) tarsi syndrome, impingement, tears, tendonosis, tenosynovitis, and sesamoid fractures (Labib and Slone 2015). Table 2 demonstrates the indications by body region described.
Indications - Treatment
Eleven studies described surgical procedures utilizing IONA (Fariyike et al. 2024; Gauci et al. 2021; Owusu-Sarpong et al. 2023; Andreozzi et al. 2022; Bi et al. 2023; Kirschner et al. 2023; Neal et al. 2023; Butler et al. 2023; Colasanti, Kaplan, et al. 2022; Colasanti, Mercer, et al. 2022; Kaplan et al. 2022; Garufi et al. 2023). Shoulder procedures included (1) SLAP lesion repair, (2) LHB tenodesis and/or tenotomy, and (3) subacromial decompression. Knee procedures using IONA included (1) lateral parapatellar retinacular release, (2) chondroplasty of focal cartilage lesions of the anterior femoral condyle, (3) medial meniscal repair, and (4) management of intra articular bacterial arthritis. Ankle procedures included (1) ATFL repair, (2) anterior ankle impingement debridement. Lastly, IONA was utilized for treatment for minimally invasive cheilectomy for hallux rigidus.
Clinical Evidence and Outcomes
One shoulder (Gauci et al. 2023), three knee (Andreozzi et al. 2022; Annibaldi et al. 2022; DiBartola et al. 2021) three foot and ankle (Mercer, Samsonov, et al. 2022; Butler et al. 2024; Colasanti, Mercer, et al. 2022) and one multiple-joint (McMillan et al. 2019) study evaluated outcomes following IONA. Five outcome studies compared pre- and postoperative outcomes using various validated instruments as reported in Table 3. These included: the Foot and Ankle Outcome Score (FAOS), Mean Tegner Lysholm Knee Scoring Scale (TLKSS) Mean Lysholm Score, Tegner Activity score, International Knee Documentation Committee Score (IKDS), and International Cartilage Repair Society Grades (ICRSG), Patient-Reported Outcomes Measurement Information System (PROMIS) (Mercer, Samsonov, et al. 2022; Gauci et al. 2023; Annibaldi et al. 2022; Butler et al. 2024; Colasanti, Mercer, et al. 2022).
Shoulder
Gauci et al. performed an isolated long head of the biceps tenotomy on 20 participants for isolated biceps brachii pathology and reported significant improvements in the mean visual analog score (VAS) and subjective shoulder value and Constant (Gauci et al. 2023).
Knee
Andreozzi et al. evaluated the safety and efficacy of IONA in the diagnosis of drug-resistant monoarticular inflammatory arthritis in a study comparing pre and postoperative outcomes in 12 patients. The authors reported a mean surgical time of 12 minutes with a 97% specimen achievement rate. In addition there were no iatrogenic chondral injuries. Eleven of the twelve patients reported willingness to repeat the procedure (Andreozzi et al. 2022). Annibaldi et al. demonstrated IONA is effective in assessing ACL healing in 15 patients two years after repair reporting a excellent outcomes scores including TLKSS, KOOS, and IKDC scores of 97.5, 98.1, and 96.7, respectively (Annibaldi et al. 2022).
Ankle/Foot
Colasanti et al. evaluated outcomes following IONA for ankle debridement in 31 patients with anterior ankle impingement demonstrating a 22% improvement in symptoms, 16% improvement in pain, 20% improvement in ADLs, and 28% improvement in Quality of Life (QOL) for Foot and Ankle Outcome Score (FAOS) (Colasanti, Mercer, et al. 2022). Additionally there was a 9% decrease in pain interference and a 12% decrease in pain intensity for Patient-Reported Outcomes Measurement Information System (PROMIS). Mercer et al. similarly demonstrated significant improvements in all pre-op FAOS scores after IONA for treatment of posterior ankle impingement (Mercer, Samsonov, et al. 2022). Lastly, Butler et al. evaluated IONA for Achilles tendoscopy in 12 participants (Butler et al. 2024). Post operative visual analog scale scores for golf, running, walking, weight training and other performance sports all showed significant improvement and mean patient satisfaction score was 4.5/5.
Second Look Arthroscopy with IONA
DiBartola et al. assessed horizontal cleavage tears of the medial and lateral meniscus at 6 months follow up after IONA surgical repair. All tears demonstrated complete healing with IONA. Seven patients demonstrated grade III changes pre-operatively, and 5 patients demonstrated grade III changes post-operatively (DiBartola et al. 2021).
Annibaldi et al. assessed healing of ACL repairs 14 days after surgery in 15 patients. The mean TLKSS, KOOS, and IKDC were 97.86, 98.08, and 96.71, respectively (Annibaldi et al. 2022). IONA evaluated ACL healing, tension, and synovial coverage, finding a statistically significant correlation with MRI appearance, as measured by the Howell scale for signal intensity.
Complications
Eight of the 29 studies reported complications and limitations with use of IONA (Mercer, Samsonov, et al. 2022; Daggett et al. 2020; Fariyike et al. 2024; Andreozzi et al. 2022; Bradsell et al. 2022; McMillan, Saini, et al. 2017; Patel et al. 2018; Trang et al. 2022; Butler et al. 2024). Reported complication rates were low across included studies; however, meaningful aggregation is limited by heterogeneity in reporting and absence of standardized definitions. The largest series (n = 1,419) reported no major complications and minor complication rates below 5%, most commonly vasovagal events. Given the predominance of retrospective case series and technical reports, true complication incidence remains uncertain and may be underreported (McMillan et al. 2019).
Limitations of IONA
Four studies reported that lack of fluid irrigation, normally used with surgical arthroscopy, was a frequent hindrance of visualization of the joint space in hemarthritic and synovitic patients (Daggett et al. 2020; Bradsell et al. 2022; McMillan, Saini, et al. 2017; Trang et al. 2022). Additionally, the steep learning curve of using a zero degree scope presented a challenge to surgeons in two studies (Fariyike et al. 2024; Patel et al. 2018). Future research should describe how training pathways have addressed this learning curve. Additionally, it could investigate the effectiveness of equipment familiarization pathways, such as simulation-based or structured credentialing, compare them or others to one another, and determine their association with complications or patient reported outcomes.
Technical Feasibility and Procedural Considerations
The technical literature primarily describes portal placement, positioning, anesthetic technique, and procedural pearls. These reports are descriptive in nature and are not designed to evaluate safety or effectiveness.
i. Shoulder
Patient positioning and perioperative pharmaceutical use were highlighted as important aspects of IONA procedures. The patient was positioned with the back of the seat inclined at 70 to 80 degrees. The arm of the operative shoulder was placed on a well-padded Mayo stand, slightly flexed forward and abducted, to help facilitate easier access to the glenohumeral joint. One liter ratio of epinephrine to normal saline to simultaneously improve hemostasis and visualization. Portal management best practices included using posterior and anterosuperior portals with an additional lateral working portal for subacromial impingement, ensuring the viewing portal was opposite the aspect of the lesion and waiting a minimum of 10 minutes between intra-articular local anesthetic injection and portal incision to ensure optimal patient comfort.
ii. Knee
Considerations for diagnosis of intra-articular knee pathology include proper patient set-up determined by site of the lesion. For medial and lateral compartment evaluations, authors recommend keeping the patient supine with ability to flex the knee between 45 and 90 degrees. For patellofemoral joint inspection, the knee should be extended. Portals used include anteromedial and anterolateral, ensuring placement in the “soft spot” at the periphery of the patellar tendon approximately 1cm superior to the anterior tibial slope at the level of the inferior pole of the patella. Further specifics about portal placement in the “soft spot” are provided. Additionally, 3 cubic centimeter bursts of normal saline can be used to push away soft tissue and enhance visualization at the site of inspection.
iii. Foot and ankle
For anterior ankle pathology, the patient is placed in a supine position with a cushion placed under the leg just above the ankle, allowing for plantar flexion to facilitate joint distraction. For posterior pathology, the patient is positioned prone on pillows, ensuring comfort with proper head and leg support to minimize movement. Portal sites vary with the anatomical location of the pathology. Anterior ankle pathologies were addressed using anteromedial viewing and anterolateral portals, with the former placed lateral to the medial malleolus and medial to the tibialis anterior tendon and the latter placed medial to the lateral malleolus. Posterior hindfoot and Achilles tendon pathologies were addressed with posterolateral and posteromedial portals. The arthroscopy portal sites are located, cleaned with alcohol, and each portal is injected with 10 cc of 1% lidocaine. Using sterile technique, the extremity is prepped with a chlorhexidine gluconate and isopropyl alcohol solution, then draped. After five to 10 minutes, 20 cc of a 1:1 mixture of 1% lidocaine and 0.5% bupivacaine is injected through the portal sites into the joint. Portal stab incisions are made using an 11 blade, then the standard operating room procedure is performed with an inflow and outflow fluid irrigation system with a modifiable pressure of 35mmHg. Table 4 indicates technical considerations for all studies.
Discussion
This scoping review summarizes the existing literature on the use of in-office needle arthroscopy (IONA) across multiple joints. The available evidence consists predominantly of technical reports and small, non-comparative case series that describe feasibility rather than comparative effectiveness. Although several outcome studies report short-term improvements in patient-reported measures and low rates of major complications, the predominance of low-level evidence and substantial heterogeneity preclude definitive conclusions regarding diagnostic accuracy, clinical effectiveness, or safety.
Shoulder
The shoulder represents one of the earliest and most frequently described applications of IONA, with five technical reports and a single study reporting quantitative clinical outcomes identified. Technical reports describe diagnostic visualization and treatment of select intra-articular pathologies, including long head of the biceps (LHB) tendinopathy, subacromial impingement, and superior labral pathology managed with limited debridement or tenotomy. Gauci et al. reported improvements in visual analog scale (VAS) and Subjective Shoulder Value (SSV) following in-office procedures, suggesting that patients may tolerate the intervention in this setting (Gauci et al. 2023). However, the absence of comparator groups, blinded assessments, or standardized reference standards limits interpretation of these findings beyond feasibility and short-term symptom change.
Knee
The knee literature includes seven technical reports and three outcome studies. Technical descriptions focus on diagnostic assessment of intra-articular pathology and procedural feasibility for chondral, ligamentous, and tendinous conditions, including cartilage debridement, evaluation of horizontal cleavage tears, and postoperative assessment following anterior cruciate ligament repair. Outcome studies did not consistently demonstrate clinical benefit for therapeutic intervention but did suggest potential utility for postoperative healing assessment and second-look evaluation. Notably, available data do not establish whether IONA provides incremental diagnostic or clinical value over routine physical examination and standard postoperative follow-up, particularly during active rehabilitation. Future comparative studies are required to clarify whether in-office visualization alters clinical decision-making or patient outcomes in this context.
Second-Look Arthroscopy and Synovial Biopsy
Emerging evidence suggests a role for IONA in second-look arthroscopy and synovial biopsy, particularly in inflammatory and postoperative conditions. In one study evaluating monoarticular arthritis, most patients expressed willingness to undergo repeat in-office procedures (11 of 12 patients), with high rates of successful specimen collection and short procedural duration (Andreozzi et al. 2022). While real-time intra-articular visualization may offer theoretical advantages over arthrocentesis alone, these findings remain preliminary. Interpretation is limited by verification bias, as patients undergoing IONA were already selected for invasive evaluation, and by the absence of blinded comparisons to established reference standards. To minimize such bias, blinded diagnostic accuracy designs should be included in future studies. Additionally, comparative studies evaluating diagnostic yield, clinical impact, and cost-effectiveness relative to arthrocentesis and advanced imaging are needed.
Foot and Ankle
Nine technical reports and three outcome studies describe the use of IONA in the foot and ankle. Reported diagnostic and therapeutic indications include anterior ankle impingement, ATFL pathology, cheilectomy for hallux rigidus, posterior hindfoot pathology, and tendinopathies involving the Achilles, tibialis posterior, and common peroneal tendons. Technical reports primarily describe procedural feasibility, portal placement, and visualization of intra-articular and peri-tendinous pathology.
Outcome studies report short-term improvements in patient-reported measures following IONA for anterior and posterior ankle impingement, including improvements in pain and functional domains. One outcome study evaluating IONA for healing assessment following chronic Achilles tendinopathy reported favorable functional outcomes and high patient satisfaction, with 11 of 12 patients indicating willingness to undergo the procedure again (Butler et al. 2024). In this cohort, one patient experienced a sural nerve neurapraxia that resolved within four months, and one patient reported persistent Achilles pain and stiffness refractory to physical therapy. These findings underscore the importance of careful patient selection, procedural counseling, and consideration of potential neurologic risk.
As with other joints, interpretation of these findings is limited by small sample sizes, lack of comparator groups, and short follow-up duration. No study directly compared IONA-based assessment or intervention with physical examination, rehabilitation-based evaluation, or operative arthroscopy. Accordingly, while these reports suggest technical feasibility and short-term symptom improvement in select indications, further prospective, comparative studies are needed to determine whether the potential benefits of direct in-office visualization outweigh procedural risks and whether IONA meaningfully alters clinical decision-making or outcomes in foot and ankle pathology.
Safety Considerations
Although complication rates cannot be generalized across heterogeneous procedures and indications, reported adverse events in the existing literature are infrequent and typically minor. No major complications were identified, with minor events including vasovagal episodes, transient neuropraxia, and short-term postoperative discomfort (Mercer, Azam, et al. 2022; McMillan et al. 2019; Garufi et al. 2023; Szachnowski et al. 1995; Kim et al. 2005). A larger retrospective analysis of 335 office-based knee arthroscopies, which reported major complication rates of 1.2 percent and minor complications in 12.8 percent of cases, without any long-term morbidity or mortality (Szachnowski et al. 1995). Similarly, prospective trials and systematic reviews involving the knee, ankle, and wrist have reported no device-related complications or serious adverse events (Burt et al. 2023; Gill et al. 2018). Given the majority of literature in the present study are technical reports, true complication incidence may likely be underreported. Perceived safety of this modality should be interpreted cautiously and within the context of selective patient populations and limited follow-up. Although patient-specific susceptibility may contribute, mitigation strategies such as preprocedural counseling and the use of physical counterpressure maneuvers like leg-crossing and muscle tensing may improve patient tolerance and reduce the likelihood of an event (Kim et al. 2005; Peterson and Cigrang 2003).
Other intraoperative considerations have not been discussed in the literature. In addition to vasovagal events and unlike OR-arthroscopy, IONA introduces risks specific to an awake patient: patient movement, pain response, electrocautery tolerance, bleeding management, and protocols for procedural termination or conversion must be further qualified and quantified in future literature. More robust description of patient selection criteria, pre-procedural counseling protocols, and contingency planning when patients cannot tolerate therapeutic maneuvers intraoperatively are needed as well.
Limitations
This review is limited by the nature and quality of the available evidence. Most included studies were technical reports or small, non-comparative case series, with only eight studies reporting clinical outcomes using validated measures. As such, the literature primarily reflects technical feasibility and early clinical experience rather than comparative effectiveness. Outcome reporting was highly heterogeneous, with inconsistent documentation of follow-up duration, clinical significance, and complications, precluding quantitative synthesis or meta-analysis.
Interpretation of diagnostic performance is further constrained by verification bias and the absence of blinded diagnostic accuracy studies or standardized reference standards. Additionally, demographic reporting was inconsistent across studies. Only one technical report included patient demographic data, and while most outcome studies reported age and body mass index, reporting formats varied and other potentially relevant characteristics were infrequently described (Patel et al. 2018). More consistent reporting of patient demographics and baseline characteristics would improve interpretation and generalizability. Generalizability is also limited by the characteristics of the populations studied. In-office needle arthroscopy is not universally covered by insurance, which may select for patients with higher health literacy and socioeconomic status. Further demographic correlations with undergoing elective procedures such as IONA exist (e.g, race and ethnicity) which systematically excludes portions of the broader population. Patient characteristics should be included in future research, especially for a modality that has potential to reduce time to diagnosis and treatment, a factor that has been correlated with healthcare access. Reported outcome studies also included relatively few patients with obesity, potentially limiting applicability to broader clinical populations where visualization and procedural complexity may differ. Future studies should also implement multi-surgeon and multi-center design to minimize observer bias and optimize generalizability.
Finally, outcome measures varied widely across studies, even within the same joint, with inconsistent reporting of functional outcomes, patient-reported measures, procedural metrics, and complications. As in-office needle arthroscopy continues to evolve, future investigations should prioritize prospective, comparative study designs with standardized reporting of outcomes, complications, and health system impacts to better define its clinical role.
Conclusion
The current literature on in-office needle arthroscopy consists predominantly of technical reports and small case series. Available studies suggest that IONA is technically feasible and may be associated with short-term improvements in patient-reported outcomes in select indications; however, the predominance of low-level evidence and absence of comparative studies preclude definitive conclusions regarding effectiveness, safety, or superiority over conventional arthroscopy or advanced imaging. Further prospective, comparative investigations are required before broader clinical adoption can be recommended.

